Literature DB >> 6393861

Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.

W L Whelan, D Kerridge.   

Abstract

UMP pyrophosphorylase activity was assayed in crude lysates prepared from Candida albicans. Specific activity of UMP pyrophosphorylase was high in clinical isolates which were susceptible to 5-fluorocytosine. Resistant clinical isolates displayed low activity, and partially resistant (heterozygous) isolates displayed intermediate activity. Segregation from the heterozygous state resulted in a homozygous susceptible segregant with high UMP pyrophosphorylase activity and a homozygous resistant segregant with low activity. The observed specific activities were consistent with the hypothesis that specific activity was determined by the sum of the activities due to the dominant (FCY) and recessive (fcy) alleles of the resistance gene. Strains which possessed little UMP pyrophosphorylase activity released uracil into the medium when grown in the absence of 5-fluorocytosine; this result suggested that recycling of intracellular uracil is a normal function of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393861      PMCID: PMC179965          DOI: 10.1128/AAC.26.4.570

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Uridine-5'-monophosphate pyrophosphorylase activity from Escherichia coli.

Authors:  A Molloy; L R. Finch
Journal:  FEBS Lett       Date:  1969-11-12       Impact factor: 4.124

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Mode of action of 5-fluorocytosine and mechanisms of resistance.

Authors:  A Polak; H J Scholer
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

4.  Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.

Authors:  K S Defever; W L Whelan; A L Rogers; E S Beneke; J M Veselenak; D R Soll
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

5.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

6.  Segregation of 5-fluorocytosine-resistance variants by Candida albicans.

Authors:  W L Whelan; E S Beneke; A L Rogers; D R Soll
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

7.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

8.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  8 in total
  18 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Recombinagenicity of caffeine for Candida albicans.

Authors:  A Sarachek; L A Henderson
Journal:  Mycopathologia       Date:  1990-05       Impact factor: 2.574

3.  Genetic analysis of prototrophic natural variants of Candida albicans.

Authors:  A K Goshorn; S Scherer
Journal:  Genetics       Date:  1989-12       Impact factor: 4.562

4.  Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.

Authors:  W L Whelan; D Markie; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  Characterisation of a partially purified uracil phosphoribosyltransferase from the opportunistic pathogen Candida albicans.

Authors:  H M Alloush; D Kerridge
Journal:  Mycopathologia       Date:  1994-03       Impact factor: 2.574

6.  Instability of Candida albicans hybrids.

Authors:  W L Whelan; D M Markie; K G Simpkin; R M Poulter
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

7.  A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.

Authors:  M Di Vito; F Podo; A Torosantucci; G Carpinelli; W L Whelan; D Kerridge; A Cassone
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

8.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

9.  19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.

Authors:  M O Fasoli; D Kerridge; P G Morris; A Torosantucci
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

10.  In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.

Authors:  J M Hernández Molina; J Llosá; A Martinez Brocal; A Ventosa
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.